| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 2,337 | 2,665 | 2,960 | 3,416 | 3,792 | 4,208 | 4,391 | 4,997 | 5,503 | 6,097 | 6,685 | 7,005 |
| Expenses | 1,977 | 2,250 | 2,505 | 2,774 | 3,074 | 3,337 | 3,389 | 3,832 | 4,143 | 4,396 | 4,715 | 4,902 |
| EBITDA | 360 | 415 | 455 | 642 | 718 | 871 | 1,002 | 1,165 | 1,360 | 1,701 | 1,970 | 2,103 |
| Operating Profit % | 13 % | 14 % | 14 % | 16 % | 16 % | 18 % | 21 % | 22 % | 23 % | 25 % | 26 % | 27 % |
| Depreciation | 15 | 14 | 16 | 16 | 17 | 60 | 58 | 66 | 70 | 71 | 72 | 74 |
| Interest | 1 | 3 | 2 | 4 | 2 | 9 | 18 | 19 | 16 | 12 | 11 | 20 |
| Profit Before Tax | 344 | 398 | 437 | 622 | 699 | 803 | 926 | 1,080 | 1,274 | 1,618 | 1,887 | 2,009 |
| Tax | 115 | 143 | 160 | 220 | 249 | 210 | 235 | 281 | 324 | 417 | 473 | 497 |
| Net Profit | 229 | 255 | 277 | 401 | 450 | 593 | 691 | 799 | 949 | 1,201 | 1,414 | 1,509 |
| EPS in ₹ | 107.75 | 120.12 | 130.19 | 188.81 | 211.93 | 279.04 | 325.04 | 375.87 | 446.80 | 565.28 | 665.62 | 710.10 |
Abbott
Abbott
29,455.00
+95.00
(0.32%)
Key Fundamentals
Market Cap
62,388.00 Cr
EPS
665.62
PE Ratio
43.13
Dividend Yield
1.61 %
Industry
Healthcare 52 Week High
37,000.00
52 Week Low
25,325.00
PB Ratio
14.80
Debt to Equity
0.04
Sector
Pharmaceuticals Analyst Rating and Forecast
- By Refinitiv from6 analysts
Actual
Company News
View All News
ABB India reported mixed quarterly results with net profit declining to ₹409 crore, missing analyst estimates of ₹413.3 crore and falling 7.3% from the previous year's ₹441 crore. Revenue rose 13.7% year-on-year to ₹3,310 crore, exceeding projections of ₹3,175.7 crore, driven by growth in electrification and automation segments. EBITDA decreased 7.4% to ₹500 crore with operating margin at 15.1%, down from 18.5% in the same quarter last year, reflecting cost pressures and unfavorable product mix. New orders in the capital goods sector fell approximately 20% year-on-year, excluding large one-off deals, with analysts citing muted private-sector capital expenditure and increased competition affecting demand for engineering services firms.
Abbott India Reports Strong Q2 Performance with 17% Jump in Net Profit10 hours ago
Abbott India delivered robust quarterly results with net profit rising to 4.2 billion rupees from 3.6 billion rupees year-over-year. The pharmaceutical company's EBITDA increased to 5 billion rupees compared to 4.38 billion rupees in the same period last year. EBITDA margin improved to 28.58% from 26.85% year-over-year, indicating enhanced operational efficiency and profitability.
ABB India launched new variable speed drive modules at its Peenya factory in Bengaluru, increasing local production capacity by 25%. The expansion enables the company to cut delivery times by up to 40% and produce customized drives for buildings, data centers, water, cement, and metals industries. The new manufacturing line features integrated robotics for automated production and can handle large batches with speed and precision. ABB India marks two decades of drives production in India with this expansion. The company previously secured a ₹173.55 crore order in August to supply wind turbine converters to Siemens Gamesa Renewable Power.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,685.90 | #1 4,05,487.60 | 38.58 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 54.39 | |
6,883.50 | 1,80,638.10 | 79.27 | 9,712.00 | 18.67 | 2,191 | 26.74 | 74.24 | |
1,501.50 | 1,21,429.70 | 22.30 | 28,409.50 | 7.12 | 5,291 | 3.71 | 39.79 | |
3,553.40 | 1,20,994.20 | 60.08 | 11,539.40 | 6.99 | 1,911 | 19.91 | 46.89 | |
1,205.20 | 1,00,153.70 | #1 17.53 | 33,741.20 | 16.73 | 5,725 | -0.38 | 36.98 | |
2,309.10 | 97,803.10 | 49.83 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 28.96 | |
936.70 | 97,775.80 | 20.00 | 23,511.00 | 18.55 | 4,615 | 34.60 | 30.29 | |
1,955.50 | 89,318.30 | 24.00 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 50.08 | |
5,643.50 | 67,721.60 | 28.92 | 13,458.30 | 3.70 | 2,216 | 21.39 | 62.15 | |
1,140.60 | 66,739.90 | 19.54 | 32,345.60 | 9.43 | 3,484 | 3.81 | 59.80 |
Growth Rate
Revenue Growth
9.64 %
Net Income Growth
17.75 %
Cash Flow Change
-16.57 %
ROE
2.86 %
ROCE
-0.57 %
EBITDA Margin (Avg.)
5.63 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,374 | 1,617 | 2,066 | 2,416 | 2,941 | 3,547 | 3,840 | 4,224 | 4,556 | 5,194 | 5,917 |
| Fixed Assets | 96 | 109 | 110 | 81 | 105 | 270 | 251 | 271 | 237 | 225 | 336 |
| Current Assets | 1,226 | 1,451 | 1,893 | 2,266 | 2,761 | 3,205 | 3,519 | 3,853 | 3,025 | 3,246 | 4,742 |
| Capital Work in Progress | 4 | 3 | 6 | 2 | 1 | 2 | 1 | 1 | 4 | 10 | 18 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,274 | 1,505 | 1,950 | 2,333 | 2,835 | 3,275 | 3,589 | 3,953 | 4,315 | 4,958 | 5,563 |
| Total Liabilities | 1,374 | 1,617 | 2,066 | 2,416 | 2,941 | 3,547 | 3,840 | 4,224 | 4,556 | 5,194 | 5,917 |
| Current Liabilities | 397 | 382 | 632 | 668 | 857 | 891 | 1,031 | 1,203 | 1,206 | 1,343 | 1,407 |
| Non Current Liabilities | 39 | 39 | 47 | 55 | 75 | 224 | 207 | 201 | 161 | 152 | 277 |
| Total Equity | 938 | 1,196 | 1,387 | 1,693 | 2,009 | 2,432 | 2,602 | 2,820 | 3,189 | 3,699 | 4,233 |
| Reserve & Surplus | 916 | 1,174 | 1,366 | 1,672 | 1,987 | 2,410 | 2,581 | 2,799 | 3,167 | 3,678 | 4,212 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -30 | 91 | 62 | -165 | 99 | 8 | 73 | -86 | 107 | 52 | 269 |
| Investing Activities | -187 | -77 | -155 | -215 | -257 | -401 | -72 | -396 | -148 | -416 | 182 |
| Operating Activities | 215 | 249 | 307 | 153 | 499 | 626 | 727 | 948 | 893 | 1,213 | 1,012 |
| Financing Activities | -58 | -80 | -90 | -102 | -143 | -217 | -582 | -637 | -639 | -745 | -925 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.18 % | 0.18 % | 0.18 % | 0.16 % | 0.16 % | 0.16 % | 0.16 % | 0.16 % |
| DIIs | 4.60 % | 5.80 % | 4.30 % | 4.20 % | 4.96 % | 5.24 % | 7.73 % | 8.39 % | 8.62 % | 8.67 % | 8.71 % | 8.74 % | 8.91 % | 8.81 % | 8.99 % | 9.01 % | 8.92 % | 9.19 % | 9.11 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 16.15 % | 15.83 % | 15.60 % | 15.81 % | 15.15 % | 14.72 % | 14.60 % | 14.25 % | 14.07 % | 13.95 % | 13.89 % | 13.97 % | 13.80 % | 13.86 % | 13.65 % | 13.59 % | 13.66 % | 13.35 % | 13.43 % |
| Others | 4.26 % | 3.38 % | 5.11 % | 5.01 % | 4.91 % | 5.06 % | 2.68 % | 2.37 % | 2.32 % | 2.39 % | 2.42 % | 2.13 % | 2.12 % | 2.16 % | 2.21 % | 2.25 % | 2.28 % | 2.31 % | 2.31 % |
| No of Share Holders | 0 | 84,478 | 75,540 | 73,417 | 83,236 | 90,567 | 82,113 | 83,526 | 72,086 | 69,582 | 68,885 | 72,252 | 69,382 | 71,588 | 69,449 | 67,892 | 69,934 | 67,584 | 71,199 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 40 | 55 | 65 | 250 | 275 | 275 | 325 | 410 | 475 |
| Dividend Yield (%) | 0.00 | 0.73 | 0.75 | 0.42 | 1.67 | 1.55 | 1.26 | 1.2 | 1.33 | 1.62 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 06 Nov 2025 |  Quarterly Result Announcement | NA | 06 Nov 2025 | 29,770.00 | 29,366.35 |
| 21 Jul 2021 |  Dividend | ₹ 155.00 /share | 19 Jul 2021 | 16,224.75 | 17,427.95 |
| 21 Jul 2021 | Dividend | ₹ 120.00 /share | 19 Jul 2021 | 16,224.75 | 17,427.95 |
| 04 Aug 2022 | Dividend | ₹ 130.00 /share | 02 Aug 2022 | 16,529.20 | 20,621.45 |
| 04 Aug 2022 | Dividend | ₹ 145.00 /share | 02 Aug 2022 | 16,529.20 | 20,621.45 |
| 21 Jul 2023 | Dividend | ₹ 145.00 /share | 21 Jul 2023 | 20,970.55 | 23,665.10 |
| 21 Jul 2023 | Dividend | ₹ 180.00 /share | 21 Jul 2023 | 20,970.55 | 23,665.10 |
| 19 Jul 2024 | Dividend | ₹ 410.00 /share | 19 Jul 2024 | 25,945.60 | 28,795.65 |
| 08 Aug 2024 |  Annual General Meeting | NA | 08 Aug 2024 | 25,945.60 | 28,136.85 |
| 07 Nov 2024 | Quarterly Result Announcement | NA | 07 Nov 2024 | 28,526.15 | 29,115.20 |
| 05 Feb 2025 | Quarterly Result Announcement | NA | 05 Feb 2025 | 26,518.15 | 26,142.55 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 30,145.75 | 30,348.45 |
| 25 Jul 2025 | Dividend | ₹ 475.00 /share | 25 Jul 2025 | 30,348.45 | 34,580.00 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 33,595.00 | 32,980.00 |
| 13 Aug 2025 | Annual General Meeting | NA | 13 Aug 2025 | 30,348.45 | 32,342.10 |
Announcements
Unaudited Financial Results For The Quarter Ended September 30 2025.
10 hours ago
10 hours agoBoard Meeting Outcome for Outcome Of Board Meeting10 hours ago
10 hours agoBoard Meeting Intimation for Intimation Under Regulation 29(1)(A) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.8 days ago
8 days ago Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 24, 2025
Sep 24, 2025Closure of Trading WindowSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 12, 2025
Sep 12, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotSep 11, 2025
Sep 11, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Aug 13, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 13, 2025
Aug 13, 2025Unaudited Financial Results For The Quarter Ended June 30 2025.Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Aug 12, 2025Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended On June 30 2025.Aug 04, 2025
Aug 04, 2025Disclosure Under Regulation 30Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Jul 29, 2025Communication Providing The Weblink Including Path Of Annual Report.Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Jul 18, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 18, 2025
Jul 18, 2025Notice Of The 81St Annual General Meeting Of The Company.Jul 18, 2025
Jul 18, 2025Reg. 34 (1) Annual Report.Jul 18, 2025
Jul 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Communication To Shareholders : Intimation About Tax Deduction At Source On Dividend.Jun 18, 2025
Jun 18, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2025
May 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Record Date For Entitlement Of DividendMay 15, 2025
May 15, 2025Annual General Meeting On August 13 2025May 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
May 15, 2025Results For The Financial Year Ended March 31 2025May 15, 2025
May 15, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 07, 2025
May 07, 2025Board Meeting Intimation for Intimation Under Regulation 29 (1) (A) And (E) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.May 07, 2025
May 07, 2025Announcement Under Regulation 30.Apr 30, 2025
Apr 30, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 24, 2025
Apr 24, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 18, 2025
Apr 18, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2025
Apr 16, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 01, 2025
Apr 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Rumour verification - Regulation 30(11)Mar 06, 2025
Mar 06, 2025Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 27, 2025
Feb 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 20, 2025
Feb 20, 2025Integrated Filing (Financial)Feb 06, 2025
Feb 06, 2025Mutual Fund Holdings
SBI Large & Midcap Fund Direct Plan-Growth 
Axis Midcap Direct Plan-Growth 
Canara Robeco Large and Mid Cap Fund Direct-Growth 
Nippon India Multi Cap Fund Direct-Growth 
PGIM India Midcap Fund Direct-Growth 
Franklin India Mid Cap Fund Direct-Growth 
HSBC Midcap Fund Direct-Growth 
Edelweiss Balanced Advantage Fund Direct-Growth 
LIC MF Large & Mid Cap Fund Direct-Growth 
WhiteOak Capital Mid Cap Fund Direct - Growth 
UTI MNC Fund Direct-Growth 
Baroda BNP Paribas Midcap Fund Direct-Growth 
Mahindra Manulife Mid Cap Fund Direct - Growth 
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth 
Tata India Pharma & Healthcare Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 39.19
ATR(14)
Volatile 502.80
STOCH(9,6)
Oversold 17.88
STOCH RSI(14)
Oversold 17.66
MACD(12,26)
Bearish -24.24
ADX(14)
Strong Trend 25.05
UO(9)
Bearish 37.21
ROC(12)
Downtrend And Accelerating -1.59
WillR(14)
Neutral -62.78
About Abbott
Abbott India Ltd is a leading multinational pharmaceutical company in India. It operates an owned manufacturing facility in Goa and works with various independent contract manufacturers across the country. The company sells its products primarily within India through independent distributors. Abbott India provides pharmaceutical products and solutions across various therapeutic areas including Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, and Consumer Health. The company is structured into four divisions: Primary Care, Specialty Care-Methabolics and Urology, Specialty Care-Neuroscience, and Hospital Care. Abbott India manufactures and markets a wide range of products including Brufen, Prothiaden, Thyronorm, Leptos, Digene, Cremaffin, Influvac, and many others. The company has expanded its product portfolio through launches, acquisitions, and partnerships over the years. Abbott India is engaged in research and development, conducting clinical studies and publishing in medical journals. The company has also been recognized for innovation in the pharmaceutical industry.
Website
Chairperson NameMunir Shaikh
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
